Shurong Zhou

No. 38, Xueyuan Road
Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Journal: Molecular pharmaceutics

Published: July 01, 2026

Natural polysaccharides as immune adjuvants to overcome immune checkpoint inhibitor resistance: mechanistic insights, clinical evidence, and translational challenges.

Natural polysaccharides as immune adjuvants to overcome immune checkpoint inhibitor resistance: mechanistic insights, clinical evidence, and translational challenges.

Journal: Frontiers in immunology

Published: June 21, 2026

Author Correction: Small circular RNAs as vaccines for cancer immunotherapy.

Author Correction: Small circular RNAs as vaccines for cancer immunotherapy.

Journal: Nature biomedical engineering

Published: August 12, 2025

Engineering circular guide RNA and CRISPR-Cas13d-encoding mRNA for the RNA editing of Adar1 in triple-negative breast cancer immunotherapy.

Engineering circular guide RNA and CRISPR-Cas13d-encoding mRNA for the RNA editing of Adar1 in triple-negative breast cancer immunotherapy.

Journal: bioRxiv : the preprint server for biology

Published: August 08, 2025

Pulmonary delivery of small circular RNA vaccines for influenza prevention.

Pulmonary delivery of small circular RNA vaccines for influenza prevention.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 01, 2025

Combined cancer immunotherapy with lipid nanoparticle delivery of oligo-based cGAS-agonistic adjuvant and peptide or mRNA vaccines.

Combined cancer immunotherapy with lipid nanoparticle delivery of oligo-based cGAS-agonistic adjuvant and peptide or mRNA vaccines.

Journal: Molecular therapy. Nucleic acids

Published: April 11, 2025

Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma.

Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma.

Journal: bioRxiv : the preprint server for biology

Published: November 22, 2024

Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy.

Engineering cGAS-agonistic oligonucleotides as therapeutics for cancer immunotherapy.

Journal: Molecular therapy. Nucleic acids

Published: November 19, 2023

Engineering cGAS-agonistic oligonucleotides as therapeutics and vaccine adjuvants for cancer immunotherapy.

Engineering cGAS-agonistic oligonucleotides as therapeutics and vaccine adjuvants for cancer immunotherapy.

Journal: bioRxiv : the preprint server for biology

Published: July 28, 2023

Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect.

Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect.

Journal: Science advances

Published: July 14, 2023

Small circular RNAs as vaccines for cancer immunotherapy.

Small circular RNAs as vaccines for cancer immunotherapy.

Journal: Nature biomedical engineering

Published: May 30, 2023

Targeting Lymph Nodes for Systemic Immunosuppression Using Cell-Free-DNA-Scavenging And cGAS-Inhibiting Nanomedicine-In-Hydrogel for Rheumatoid Arthritis Immunotherapy.

Targeting Lymph Nodes for Systemic Immunosuppression Using Cell-Free-DNA-Scavenging And cGAS-Inhibiting Nanomedicine-In-Hydrogel for Rheumatoid Arthritis Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 23, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026